DukeKBahnMD

Radiology • Ventura, CA

Director, Prostate Institute of America, Ventura, CA Clinical Professor of Urology, University of Southern California

Join to view full profile

Dr. Bahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bahn's full profile

Already have an account?

Office
168 N Brent St
#402
Ventura, CA 93003
Phone+1 888-234-0004

Fax+1 888-641-3965

Education & Training

Detroit Medical Center/Wayne State UniversityResidency, Radiology-Diagnostic, 1977 - 1978
Detroit Medical Center/Wayne State UniversityResidency, Radiology-Diagnostic, 1975 - 1977
Ascension St John HospitalInternship, Transitional Year, 1974 - 1975
Catholic University Medical CollegeClass of 1970

Certifications & Licensure

CA State Medical License 2002 - 2025
AZ State Medical License 1999 - 2019
MI State Medical License 1975 - 2019
American Board of Radiology Diagnostic Radiology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2008-2013
Top Doctors:Southern California Castle Connolly, 2012
Join now to see all

Clinical Trials

Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer Start of enrollment: 2009 Aug 01
Terminated
Phase 1, Phase 2
Salvage Cryotherapy in Recurrent Prostate Cancer Start of enrollment: 2007 Jan 01
Terminated

Publications & Presentations

PubMed

5 citations
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Liv Cecilie Vestrheim Thomsen, Alfred Honoré, Lars Anders Rokne Reisæter, Bjarte Almås, Astrid Børretzen
Cancer Immunology, Immunotherapy. 2023-07-01
11 citations
Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation.
Alireza Ghoreifi, Masatomo Kaneko, Samuel Peretsman, Atsuko Iwata, Jessica Brooks
European Urology Open Science. 2023-04-01
1 citations
Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up
Akbar Ashrafi, Toshitaka Shin, Arnaud Marien, Thomas G. Clifford, Sunao Shoji
World Journal of Urology. 2021-03-08

Other Languages

Korean